scholarly article | Q13442814 |
P50 | author | Benoit Chassaing | Q56154430 |
Andrew T Gewirtz | Q100427123 | ||
P2093 | author name string | Behtash Ghazi Nezami | |
Shanthi Srinivasan | |||
Matam Vijay-Kumar | |||
François Reichardt | |||
Mallappa Anitha | |||
Simon Mwangi | |||
Sahar Tabatabavakili | |||
P2860 | cites work | Gut Microbiota and Its Possible Relationship With Obesity | Q22241118 |
Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
Lipopolysaccharide-induced loss of cultured rat myenteric neurons - role of AMP-activated protein kinase | Q28542433 | ||
Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility | Q33428466 | ||
Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon | Q33735955 | ||
AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition | Q33872260 | ||
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 | ||
Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons | Q34094965 | ||
Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans | Q34143553 | ||
Physiology, injury, and recovery of interstitial cells of Cajal: basic and clinical science | Q34145366 | ||
American Gastroenterological Association medical position statement on constipation | Q34319115 | ||
American Gastroenterological Association technical review on constipation | Q34319119 | ||
Effect of 6-month adherence to a very low carbohydrate diet program | Q34525074 | ||
Modulation of lipopolysaccharide-induced neuronal response by activation of the enteric nervous system | Q34789106 | ||
TLR4 is required for the obesity-induced pancreatic beta cell dysfunction | Q34975821 | ||
High-fat diet alters gut microbiota physiology in mice | Q34986213 | ||
Enteric neuropathy can be induced by high fat diet in vivo and palmitic acid exposure in vitro | Q35061242 | ||
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice | Q35405358 | ||
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota | Q35799019 | ||
Association of high dietary saturated fat intake and uncontrolled diabetes with constipation: evidence from the National Health and Nutrition Examination Survey | Q36096067 | ||
Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis | Q36119099 | ||
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. | Q36145284 | ||
Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling | Q36279376 | ||
The microbiota link to irritable bowel syndrome: an emerging story | Q36392101 | ||
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal | Q37003216 | ||
Characterization of fetal and postnatal enteric neuronal cell lines with improvement in intestinal neural function | Q37034295 | ||
Expression and activity of the TLR4/NF-κB signaling pathway in mouse intestine following administration of a short-term high-fat diet | Q37207326 | ||
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia | Q37389400 | ||
High-fat diet determines the composition of the murine gut microbiome independently of obesity | Q37404989 | ||
Effect of high fat-diet and obesity on gastrointestinal motility | Q37473305 | ||
The involvement of nitric oxide synthase neurons in enteric neuropathies. | Q37927166 | ||
High-fat diet promotes neuronal loss in the myenteric plexus of the large intestine in mice. | Q38303452 | ||
High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes | Q38457192 | ||
Early inflammatory damage to intestinal neurons occurs via inducible nitric oxide synthase | Q38922749 | ||
MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice | Q39026058 | ||
Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells | Q39287275 | ||
Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling | Q39511870 | ||
Enteric neuroblasts require the phosphatidylinositol 3-kinase/Akt/Forkhead pathway for GDNF-stimulated survival | Q40428305 | ||
Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. | Q42942520 | ||
Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention. | Q43369271 | ||
Isoquercetin protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via suppression of TLR4-NF-кB signal pathway | Q44083066 | ||
Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway | Q44129326 | ||
Effect of cafeteria diet on the gastrointestinal transit and emptying in the rat. | Q44976997 | ||
Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. | Q45739447 | ||
The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse | Q46127686 | ||
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model | Q48504480 | ||
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. | Q48516420 | ||
Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | Q50468098 | ||
Randomised, double-blind and placebo-controlled study of the effect of a synbiotic dairy product on orocecal transit time in healthy adult women. | Q50500190 | ||
Plasma fatty acid levels in infants and adults after myocardial ischemia. | Q51630314 | ||
Fatty diets retarded the propulsive function of and attenuated motility in the gastrointestinal tract of rats. | Q53337007 | ||
Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice | Q61648712 | ||
Accurate measurement of intestinal transit in the rat | Q71069600 | ||
Direct medical costs of constipation in the United States | Q79713983 | ||
Constipation and colonic transit times in children with morbid obesity | Q83217924 | ||
P433 | issue | 3 | |
P921 | main subject | dysbiosis | Q269334 |
P304 | page(s) | 328-339 | |
P577 | publication date | 2016-05-01 | |
P1433 | published in | Cellular and molecular gastroenterology and hepatology | Q27726289 |
P1476 | title | Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice | |
P478 | volume | 2 |
Q43083601 | Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. |
Q58089214 | Advances in Enteric Neurobiology: The "Brain" in the Gut in Health and Disease |
Q54976966 | Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review. |
Q47795925 | Epithelial Organization: The Gut and Beyond |
Q52610914 | Fecal imaging demonstrates that low-methoxyl pectin supplementation normalizes gastro-intestinal transit in mice given a liquid diet. |
Q49348891 | Feeding Immunity: Physiological and Behavioral Responses to Infection and Resource Limitation |
Q47164064 | Genes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide. |
Q89104008 | Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion |
Q89982461 | Gut epithelial metabolism as a key driver of intestinal dysbiosis associated with noncommunicable diseases |
Q42389629 | High-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic Transit: Is There a Missing Link? |
Q90304410 | High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy |
Q92674252 | Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease |
Q57492010 | Inflammasome: A Double-Edged Sword in Liver Diseases |
Q90787665 | Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity |
Q42172913 | Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. |
Q57300026 | Microbial Changes and Host Response in F344 Rat Colon Depending on Sex and Age Following a High-Fat Diet |
Q55061103 | Prevalence of Functional Constipation and Relationship with Dietary Habits in 3- to 8-Year-Old Children in Japan. |
Q90232667 | Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors |
Q52639070 | Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease. |
Q52594157 | The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity. |
Q40401028 | Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharide-induced TLR4 signalling. |